BAY-293

BAY-293 Suppliers list
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  Gold
Tel: 15000803246 18149758185
Email: sales-cpd@caerulumpharma.com
Company Name: Shanghai Topbiochem Technology Co., Ltd  
Tel: 021-58170097
Email: info@topbiochem.com
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  
Tel: 18149758185 18149758185
Email: sales-cpd@caerulumpharma.com
Company Name: Bide Pharmatech Ltd.  
Tel: 400-164-7117 18317119277
Email: product02@bidepharm.com
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696,15000506266 15000506266
Email:

BAY-293 manufacturers

  • BAY-293
  • BAY-293 pictures
  • $48.00
  • 2026-07-27
  • CAS:2244904-70-7
  • Purity: 97.16%
  • Supply Ability: 10g
  • BAY-293
  • BAY-293 pictures
  • 2026-07-22
  • CAS:2244904-70-7
  • Min. Order: 1KG
  • Purity: 98%
  • Supply Ability: 1000kg
BAY-293 Basic information
Product Name:BAY-293
Synonyms:BAY-293;(R)-(6,7-Dimethoxy-2-methyl-quinazolin-4-yl)-[1-[4-(2-methylaminomethyl-phenyl)-thiophen-2-yl]-ethyl]-amine;BAY-293;BAY 293;BAY293;(R)-6,7-dimethoxy-2-methyl-N-(1-(4-(2-((methylamino)methyl)phenyl)thiophen-2-yl)ethyl)quinazolin-4-amine;4-Quinazolinamine, 6,7-dimethoxy-2-methyl-N-[(1R)-1-[4-[2-[(methylamino)methyl]phenyl]-2-thienyl]ethyl]-;6,7-dimethoxy-2-methyl-N-[(1R)-1-[4-[2-(methylaminomethyl)phenyl]-2-thienyl]ethyl]quinazolin-4-amine;Inhibitor,BAY-293,BAY293,inhibit,BAY 293,Ras;BAY-293, 10 mM in DMSO
CAS:2244904-70-7
MF:C25H28N4O2S
MW:448.58
EINECS:
Product Categories:
Mol File:2244904-70-7.mol
BAY-293 Structure
BAY-293 Chemical Properties
Boiling point 553.4±50.0 °C(Predicted)
density 1.218±0.06 g/cm3(Predicted)
storage temp. 2-8°C(protect from light)
solubility DMSO: soluble
form A solid
pka9.61±0.10(Predicted)
color White to light yellow
Optical Rotation[α]/D -85.0 to -103.0°, c =1.0 in DMSO
InChIKeyWEGLOYDTDILXDA-OAHLLOKOSA-N
SMILESN1=C2C(C=C(OC)C(OC)=C2)=C(N[C@@H](C2SC=C(C3=CC=CC=C3CNC)C=2)C)N=C1C
Safety Information
WGK Germany WGK 3
Storage Class11 - Combustible Solids
MSDS Information
BAY-293 Usage And Synthesis
Uses6,7-Dimethoxy-2-methyl-N-[(1R)-1-[4-[2-[(methylamino)methyl]phenyl]-2-thienyl]ethyl]-4-quinazolinamine is an effective and selective inhibitor of SOS1, blocking RAS activation via disruption of the KRAS-SOS1 interaction without significantly targeting the EGFR receptor. Thus, it has potential use in treatment of hyperproliferative disorders.
Biological ActivityBAY-293 selectively inhibits SOS1-mediated KRAS activation (IC50 = 52 nM; 50 nM wt or G12C hKRAS & 10 nM SOS1cat) via direct SOS1 binding, blocking SOS1-KRAS interaction (IC50 = 21 nM; 10 nM hSOS1c at & 5 nM hKRAS G12C) without affecting (IC50 >20 μM) CRAF RBD-KRAS interaction, KRAS G12C activation by SOS2, Cdc42 activation by DBS, or EGFR kinase activity. BAY-293 downregulates cellular active RAS (IC50 = 200 nM/Calu-1, 410 nM/HeLa) and downstream ERK phosphorylation (K-562, 150 nM/Calu-1) with good target selectivity as assessed over 358 kinases (<37% inhibition at 1 μM) and a panel of 77 GPCRs, transporters, nuclear receptors and enzymes.
IC 50KRAS-SOS1: 21 nM (IC50)
storageStore at -20°C
BAY-293 Preparation Products And Raw materials
Tag:BAY-293(2244904-70-7) Related Product Information
BAY-293 (S)-BAY-293 Glecirasib BI-2493 Garsorasib Benzo[b]thiophene-3-carbonitrile, 2-amino-4-[(4aS)-8-chloro-10-fluoro-2,3,4,4a,5,6-hexahydro-12-oxo-3-(1-oxo-2-propen-1-yl)-1H,12H-pyrazino[2,1-d][1,5]benzoxazocin-9-yl]-7-fluoro-, (4R)-